Bibi Das, MD
Psychiatry · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Research they published
4 papers · cited 35 times
Published as Bibi Das at Stanford Medicine, Stanford University.
Research identity is not a guarantee of current clinical practice. Same name is not the same person — if this looks like someone else, tell us.
| 2003 | Correlates of sexually transmitted disease infection among adults living with HIV | International Journal of STD & AIDS |
| 2002 | Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders | Bipolar Disorders |
Topics: Schizophrenia research and treatment · HIV/AIDS Research and Interventions · Electoral Systems and Political Participation · Social and Intergroup Psychology · Reproductive tract infections research
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Das’s office at (650) 498-5710 to ask if they take your plan before you enroll.
California Medical Board record
Licence A8212 · Deceased
Licence status: Deceased · since 1938 · Temple University School of Medicine.
Licensee is deceased.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$75,648
Pharmacies billed $75,648 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 366) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
312 generic and 54 brand-name prescriptions · $75,648 in drug cost · 37 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trintellix | 12 | $5,914 | $493 |
| Venlafaxine | 20 | $2,485 | $124 |
| Dexmethylphenidate Hcl Er | 12 | $1,811 | $151 |
| Desvenlafaxine Succinate Er | 20 | $1,099 | $55 |
| Eszopiclone | 15 | $1,000 | $67 |
See all 15 drugs
| Trintellix | 12 | $5,914 | $493 |
| Venlafaxine | 20 | $2,485 | $124 |
| Dexmethylphenidate Hcl Er | 12 | $1,811 | $151 |
| Desvenlafaxine Succinate Er | 20 | $1,099 | $55 |
| Eszopiclone | 15 | $1,000 | $67 |
| Dextroamphetamine-Amphet Er | 11 | $656 | $60 |
| Quetiapine | 29 | $607 | $21 |
| Lamotrigine | 29 | $585 | $20 |
| Gabapentin | 17 | $501 | $29 |
| Lithium Carbonate | 13 | $190 | $15 |
| Trazodone | 14 | $182 | $13 |
| Clonazepam | 12 | $165 | $14 |
| Zolpidem | 17 | $130 | $8 |
| Topiramate | 11 | $73 | $7 |
| Lorazepam | 12 | $67 | $6 |
Year by year
| 2024 | 366 | 18 | 0% (0) | 15% | $75,648 |
| 2023 | 474 | 18 | 0% (0) | 14% | $124,885 |
| 2022 | 362 | 15 | 0% (0) | 11% | $62,004 |
| 2021 | 301 | None | 0% (0) | 17% | $56,578 |
| 2020 | 142 | None | 0% (0) | 14% | $45,510 |
| 2019 | 140 | None | 0% (0) | 21% | $59,960 |
| 2018 | 121 | None | 0% (0) | 15% | $18,763 |
| 2017 | 136 | None | 0% (0) | 38% | $28,785 |
| 2016 | 170 | None | 0% (0) | 33% | $28,646 |
| 2015 | 41 | None | 0% (0) | None | $3,758 |
| 2014 | 26 | None | 0% (0) | 0% | $309 |
| 2013 | 12 | None | 0% (0) | None | $1,002 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Lybalvi | 12 | $17,508 | $1,459 |
| Trintellix | 18 | $9,109 | $506 |
| Desvenlafaxine Succinate Er | 31 | $2,973 | $96 |
| Gabapentin | 27 | $814 | $30 |
| Venlafaxine | 23 | $694 | $30 |
| Lamotrigine | 35 | $681 | $19 |
| Quetiapine | 43 | $481 | $11 |
| Topiramate | 20 | $479 | $24 |
| Trazodone | 33 | $240 | $7 |
| Clonazepam | 17 | $211 | $12 |
| Lithium Carbonate | 14 | $200 | $14 |
| Zolpidem | 16 | $111 | $7 |
| Alprazolam | 15 | $93 | $6 |
| Propranolol | 11 | $75 | $7 |
| Buspirone | 11 | $71 | $6 |
| Lorazepam | 14 | $32 | $2 |
2022: 11 drugs
| Dextroamphetamine Sulfate Er | 11 | $3,016 | $274 |
| Desvenlafaxine Succinate Er | 26 | $1,903 | $73 |
| Gabapentin | 35 | $1,314 | $38 |
| Quetiapine | 35 | $845 | $24 |
| Lamotrigine | 21 | $519 | $25 |
| Trazodone | 27 | $297 | $11 |
| Venlafaxine | 11 | $294 | $27 |
| Clonazepam | 15 | $224 | $15 |
| Eszopiclone | 23 | $181 | $8 |
| Zolpidem | 13 | $137 | $11 |
| Alprazolam | 14 | $93 | $7 |
2021: 13 drugs
| Rexulti | 14 | $17,763 | $1,269 |
| Eszopiclone | 20 | $1,707 | $85 |
| Trazodone | 24 | $1,167 | $49 |
| Gabapentin | 37 | $1,156 | $31 |
| Desvenlafaxine Succinate Er | 17 | $920 | $54 |
| Dextroamphetamine Sulfate Er | 11 | $595 | $54 |
| Quetiapine | 18 | $522 | $29 |
| Lamotrigine | 21 | $408 | $19 |
| Clonazepam | 12 | $150 | $13 |
| Zolpidem | 12 | $130 | $11 |
| Lorazepam | 15 | $124 | $8 |
| Paroxetine | 12 | $122 | $10 |
| Dextroamphetamine Sulfate | 11 | $42 | $4 |
2020: 4 drugs
| Eszopiclone | 18 | $1,823 | $101 |
| Gabapentin | 13 | $435 | $33 |
| Clonazepam | 15 | $211 | $14 |
| Zolpidem | 11 | $49 | $4 |
2019: 5 drugs
| Vraylar | 16 | $28,390 | $1,774 |
| Desvenlafaxine Succinate Er | 16 | $1,462 | $91 |
| Gabapentin | 20 | $1,349 | $67 |
| Quetiapine | 13 | $248 | $19 |
| Clonazepam | 12 | $131 | $11 |
2018: 3 drugs
| Desvenlafaxine Succinate Er | 15 | $1,243 | $83 |
| Gabapentin | 19 | $473 | $25 |
| Clonazepam | 17 | $178 | $10 |
2017: 4 drugs
| Latuda | 15 | $16,626 | $1,108 |
| Lyrica | 11 | $2,818 | $256 |
| Synthroid | 12 | $415 | $35 |
| Clonazepam | 15 | $76 | $5 |
2016: 5 drugs
| Duloxetine | 13 | $530 | $41 |
| Synthroid | 12 | $397 | $33 |
| Bupropion Xl | 18 | $327 | $18 |
| Gabapentin | 13 | $216 | $17 |
| Clonazepam | 16 | $95 | $6 |
2014: 1 drug
| Lamotrigine | 12 | $141 | $12 |
Money from drug and device companies
$392,407 in 2025
| 2025 | 11 | 456 | $328,506 | $392,407 |
| 2024 | 11 | 414 | $211,413 | $266,361 |
| 2023 | 10 | 469 | $225,568 | $288,855 |
| 2022 | 9 | 191 | $99,588 | $118,979 |
| 2021 | 8 | 119 | $52,863 | $55,622 |
| 2020 | 6 | 236 | $75,787 | $87,201 |
| 2019 | 10 | 534 | $126,237 | $161,014 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Axsome Therapeutics | Auvelity | $183,754 | 205 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $106,071 | 112 payments
|
| Neurocrine BioSciences | Ingrezza | $40,804 | 47 payments
|
| Vanda Pharmaceuticals | Fanapt | $21,454 | 25 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $19,967 | 23 payments
|
| Abbvie | Vraylar | $10,839 | 25 payments
|
See all 456 published payments
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-12-30 | Cobenfy | $2,300 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-22 | Caplyta | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-12-22 | Caplyta | $149 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-22 | Caplyta | $4,840 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-22 | Caplyta | $3,520 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-22 | Caplyta | $2,200 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-22 | Caplyta | $4,400 |
| Abbvie | Meals · 2025-12-17 | Vraylar | $30 |
| Axsome Therapeutics | Honoraria · 2025-12-17 | Auvelity | $3,038 |
| Axsome Therapeutics | Meals · 2025-12-17 | Auvelity | $131 |
| Axsome Therapeutics | Travel · 2025-12-17 | Auvelity | $339 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-17 | Caplyta | $1,320 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-12-15 | Cobenfy | $229 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-11 | Caplyta | $125 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-12-11 | Caplyta | $650 |
| Otsuka America Pharmaceutical | Paid to speak or teach · 2025-12-10 | Rexulti | $1,620 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-12-10 | Caplyta | $2,200 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-10 | Caplyta | $138 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-10 | Caplyta | $39 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-12-10 | Caplyta | $323 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-12-10 | Caplyta | $1,000 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-09 | Caplyta | $38 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-12-09 | Caplyta | $700 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-12-09 | Caplyta | $235 |
| Teva Pharmaceuticals USA | Meals · 2025-12-09 | Uzedy | $43 |
| Abbvie | Paid to speak or teach · 2025-12-04 | Vraylar | $1,350 |
| Otsuka America Pharmaceutical | Paid to speak or teach · 2025-12-03 | Rexulti | $3,564 |
| Axsome Therapeutics | Meals · 2025-12-03 | Auvelity | $48 |
| Axsome Therapeutics | Honoraria · 2025-12-03 | Auvelity | $1,350 |
| Axsome Therapeutics | Meals · 2025-12-02 | Auvelity | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-11-25 | Caplyta | $5,280 |
| Neurocrine BioSciences | Meals · 2025-11-22 | Ingrezza | $33 |
| Otsuka America Pharmaceutical | Travel · 2025-11-21 | Rexulti | $191 |
| Otsuka America Pharmaceutical | Meals · 2025-11-20 | Rexulti | $124 |
| Abbvie | Consulting · 2025-11-19 | None | $900 |
| Axsome Therapeutics | Honoraria · 2025-11-19 | Auvelity | $1,350 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-11-18 | Caplyta | $307 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-11-18 | Caplyta | $5 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-18 | Caplyta | $105 |
| Teva Pharmaceuticals USA | Meals · 2025-11-18 | Austedo Xr | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Consulting · 2025-11-17 | Caplyta | $2,090 |
| Vanda Pharmaceuticals | Meals · 2025-11-15 | Fanapt | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-13 | Cobenfy | $123 |
| Abbvie | Paid to speak or teach · 2025-11-13 | Vraylar | $3,150 |
| Axsome Therapeutics | Meals · 2025-11-11 | Auvelity | $16 |
| Teva Pharmaceuticals USA | Meals · 2025-11-07 | Austedo Xr | $23 |
| Axsome Therapeutics | Honoraria · 2025-11-06 | Auvelity | $1,350 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-11-04 | Caplyta | $303 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-11-04 | Caplyta | $237 |
| Axsome Therapeutics | Meals · 2025-10-31 | Auvelity | $35 |
| Abbvie | Meals · 2025-10-29 | Vraylar | $13 |
| Abbvie | Travel · 2025-10-29 | Vraylar | $842 |
| Abbvie | Meals · 2025-10-29 | Vraylar | $21 |
| Axsome Therapeutics | Meals · 2025-10-28 | Auvelity | $21 |
| Otsuka America Pharmaceutical | Paid to speak or teach · 2025-10-24 | Rexulti | $1,620 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-10-23 | Cobenfy | $54 |
| Axsome Therapeutics | Honoraria · 2025-10-21 | Auvelity | $4,388 |
| Axsome Therapeutics | Honoraria · 2025-10-21 | Auvelity | $1,350 |
| Axsome Therapeutics | Meals · 2025-10-21 | Auvelity | $68 |
| Axsome Therapeutics | Travel · 2025-10-21 | Auvelity | $460 |
| Axsome Therapeutics | Travel · 2025-10-21 | Auvelity | $463 |
| Axsome Therapeutics | Travel · 2025-10-21 | Auvelity | $5 |
| Axsome Therapeutics | Travel · 2025-10-21 | Auvelity | $248 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-16 | Caplyta | $50 |
| Abbvie | Meals · 2025-10-14 | Vraylar | $30 |
| Axsome Therapeutics | Meals · 2025-10-10 | Auvelity | $150 |
| Axsome Therapeutics | Honoraria · 2025-10-10 | Auvelity | $4,725 |
| Axsome Therapeutics | Meals · 2025-10-10 | Auvelity | $14 |
| Axsome Therapeutics | Travel · 2025-10-10 | Auvelity | $5 |
| Axsome Therapeutics | Travel · 2025-10-10 | Auvelity | $319 |
| Axsome Therapeutics | Travel · 2025-10-10 | Auvelity | $203 |
| Axsome Therapeutics | Travel · 2025-10-10 | Auvelity | $249 |
| Axsome Therapeutics | Meals · 2025-10-09 | Auvelity | $72 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-07 | Trintellix | $27 |
| Abbvie | Meals · 2025-09-29 | Vraylar | $9 |
| Axsome Therapeutics | Honoraria · 2025-09-26 | Auvelity | $4,725 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $35 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $40 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $20 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $29 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $15 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $5 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $21 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $72 |
| Axsome Therapeutics | Meals · 2025-09-26 | Auvelity | $53 |
| Axsome Therapeutics | Travel · 2025-09-26 | Auvelity | $231 |
| Axsome Therapeutics | Travel · 2025-09-26 | Auvelity | $301 |
| Axsome Therapeutics | Travel · 2025-09-26 | Auvelity | $285 |
| Axsome Therapeutics | Travel · 2025-09-26 | Auvelity | $231 |
| Axsome Therapeutics | Travel · 2025-09-26 | Auvelity | $20 |
| Axsome Therapeutics | Travel · 2025-09-26 | Auvelity | $421 |
| Axsome Therapeutics | Honoraria · 2025-09-25 | Auvelity | $3,038 |
| Axsome Therapeutics | Honoraria · 2025-09-24 | Auvelity | $4,388 |
| Axsome Therapeutics | Meals · 2025-09-24 | Auvelity | $112 |
| Axsome Therapeutics | Travel · 2025-09-24 | Auvelity | $836 |
| Axsome Therapeutics | Travel · 2025-09-24 | Auvelity | $258 |
| Otsuka America Pharmaceutical | Meals · 2025-09-23 | Rexulti | $33 |
| Axsome Therapeutics | Honoraria · 2025-09-23 | Auvelity | $5,738 |
| Axsome Therapeutics | Meals · 2025-09-23 | Auvelity | $123 |
| Axsome Therapeutics | Travel · 2025-09-23 | Auvelity | $219 |
| Axsome Therapeutics | Travel · 2025-09-23 | Auvelity | $1,489 |
| Axsome Therapeutics | Travel · 2025-09-23 | Auvelity | $412 |
| Axsome Therapeutics | Travel · 2025-09-23 | Auvelity | $213 |
| Axsome Therapeutics | Travel · 2025-09-23 | Auvelity | $516 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-09-18 | Caplyta | $5 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-18 | Caplyta | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-09-18 | Caplyta | $923 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-09-18 | Caplyta | $5 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-09-18 | Caplyta | $1,538 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-18 | Caplyta | $52 |
| Axsome Therapeutics | Honoraria · 2025-09-16 | Auvelity | $1,350 |
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-09-15 | Cobenfy | $2,300 |
| Axsome Therapeutics | Honoraria · 2025-09-12 | Auvelity | $3,375 |
| Axsome Therapeutics | Meals · 2025-09-12 | Auvelity | $25 |
| Axsome Therapeutics | Meals · 2025-09-12 | Auvelity | $15 |
| Axsome Therapeutics | Travel · 2025-09-12 | Auvelity | $857 |
| Axsome Therapeutics | Travel · 2025-09-12 | Auvelity | $5 |
| Axsome Therapeutics | Travel · 2025-09-12 | Auvelity | $188 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-09-11 | Caplyta | $2,200 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-09-11 | Caplyta | $3,080 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-09 | Cobenfy | $129 |
| Vanda Pharmaceuticals | Paid to speak or teach · 2025-09-09 | Fanapt | $2,940 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-09-04 | Caplyta | $206 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-04 | Caplyta | $122 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-09-03 | Caplyta | $1,320 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-09-03 | Caplyta | $1,536 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-09-03 | Caplyta | $3,520 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-03 | Caplyta | $29 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-27 | Caplyta | $318 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-27 | Caplyta | $88 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-08-27 | Ingrezza | $3,088 |
| Neurocrine BioSciences | Travel · 2025-08-27 | Ingrezza | $61 |
| Neurocrine BioSciences | Travel · 2025-08-27 | Ingrezza | $49 |
| Axsome Therapeutics | Honoraria · 2025-08-26 | Auvelity | $1,350 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-08-26 | Ingrezza | $1,900 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-22 | Caplyta | $270 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-22 | Caplyta | $53 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-08-22 | Caplyta | $4,400 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-08-22 | Caplyta | $3,080 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-22 | Caplyta | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-22 | Caplyta | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-22 | Caplyta | $63 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-22 | Caplyta | $34 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-22 | Caplyta | $101 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-22 | Caplyta | $45 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-08-22 | Caplyta | $2,200 |
| Axsome Therapeutics | Honoraria · 2025-08-19 | Auvelity | $3,038 |
| Axsome Therapeutics | Honoraria · 2025-08-19 | Auvelity | $4,725 |
| Axsome Therapeutics | Meals · 2025-08-19 | Auvelity | $27 |
| Axsome Therapeutics | Meals · 2025-08-19 | Auvelity | $71 |
| Axsome Therapeutics | Meals · 2025-08-19 | Auvelity | $92 |
| Axsome Therapeutics | Travel · 2025-08-19 | Auvelity | $422 |
| Axsome Therapeutics | Travel · 2025-08-19 | Auvelity | $10 |
| Axsome Therapeutics | Travel · 2025-08-19 | Auvelity | $82 |
| Axsome Therapeutics | Travel · 2025-08-19 | Auvelity | $487 |
| Axsome Therapeutics | Travel · 2025-08-19 | Auvelity | $177 |
| Axsome Therapeutics | Honoraria · 2025-08-15 | Auvelity | $1,350 |
| Vanda Pharmaceuticals | Paid to speak or teach · 2025-08-13 | Fanapt | $2,730 |
| Vanda Pharmaceuticals | Travel · 2025-08-13 | Fanapt | $849 |
| Vanda Pharmaceuticals | Meals · 2025-08-13 | Fanapt | $67 |
| Axsome Therapeutics | Honoraria · 2025-08-13 | Auvelity | $9,450 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $49 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $10 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $14 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $14 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $81 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $38 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $120 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $94 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $17 |
| Axsome Therapeutics | Honoraria · 2025-08-13 | Auvelity | $9,450 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $49 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $10 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $14 |
| Axsome Therapeutics | Meals · 2025-08-13 | Auvelity | $14 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $81 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $38 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $120 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $94 |
| Axsome Therapeutics | Travel · 2025-08-13 | Auvelity | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-08-13 | Caplyta | $4,400 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-08-13 | Caplyta | $3,080 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-13 | Caplyta | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-13 | Caplyta | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-13 | Caplyta | $8 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-13 | Caplyta | $50 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-13 | Caplyta | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-13 | Caplyta | $77 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-13 | Caplyta | $50 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-08-13 | Caplyta | $5,280 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-13 | Caplyta | $95 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-13 | Caplyta | $74 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-13 | Caplyta | $5 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-12 | Trintellix | $40 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-07 | Caplyta | $359 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-07 | Caplyta | $217 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-06 | Caplyta | $216 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-08-06 | Caplyta | $1,760 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-06 | Caplyta | $70 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-06 | Caplyta | $936 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-06 | Caplyta | $870 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-06 | Caplyta | $855 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-06 | Caplyta | $202 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-05 | Caplyta | $1,045 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-08-05 | Caplyta | $203 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-05 | Caplyta | $130 |
| Vanda Pharmaceuticals | Meals · 2025-08-02 | Fanapt | $33 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-01 | Cobenfy | $16 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-30 | Caplyta | $122 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-07-30 | Caplyta | $284 |
| Abbvie | Consulting · 2025-07-29 | Vraylar | $900 |
| Abbvie | Meals · 2025-07-29 | Vraylar | $27 |
| Axsome Therapeutics | Travel · 2025-07-25 | Auvelity | $407 |
| Axsome Therapeutics | Travel · 2025-07-25 | Auvelity | $867 |
| Axsome Therapeutics | Travel · 2025-07-25 | Auvelity | $407 |
| Axsome Therapeutics | Travel · 2025-07-25 | Auvelity | $867 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-07-23 | Caplyta | $1,320 |
| Abbvie | Meals · 2025-07-22 | Vraylar | $35 |
| Abbvie | Paid to speak or teach · 2025-07-17 | Vraylar | $2,250 |
| Axsome Therapeutics | Education · 2025-07-17 | Auvelity | $52 |
| Axsome Therapeutics | Education · 2025-07-17 | Auvelity | $61 |
| Axsome Therapeutics | Meals · 2025-07-16 | Auvelity | $150 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-07-16 | Caplyta | $2,200 |
| Axsome Therapeutics | Meals · 2025-07-15 | Auvelity | $32 |
| Axsome Therapeutics | Meals · 2025-07-08 | Auvelity | $8 |
| Axsome Therapeutics | Honoraria · 2025-07-08 | Auvelity | $1,350 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-08 | Caplyta | $33 |
| Abbvie | Travel · 2025-07-07 | Vraylar | $187 |
| Abbvie | Meals · 2025-07-07 | Vraylar | $21 |
| Axsome Therapeutics | Meals · 2025-07-01 | Auvelity | $14 |
| Abbvie | Meals · 2025-06-30 | Vraylar | $29 |
| Axsome Therapeutics | Honoraria · 2025-06-24 | Auvelity | $1,350 |
| Otsuka America Pharmaceutical | Paid to speak or teach · 2025-06-23 | Rexulti | $1,620 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-06-18 | Caplyta | $3,520 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-06-13 | Cobenfy | $1,117 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-13 | Cobenfy | $10 |
| Vanda Pharmaceuticals | Meals · 2025-06-12 | Fanapt | $124 |
| Vanda Pharmaceuticals | Paid to speak or teach · 2025-06-12 | Fanapt | $3,150 |
| Vanda Pharmaceuticals | Travel · 2025-06-12 | Fanapt | $153 |
| Vanda Pharmaceuticals | Travel · 2025-06-12 | Fanapt | $279 |
| Vanda Pharmaceuticals | Travel · 2025-06-12 | Fanapt | $259 |
| Vanda Pharmaceuticals | Meals · 2025-06-12 | Fanapt | $12 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-06-12 | Caplyta | $607 |
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-06-10 | Cobenfy | $2,760 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-10 | Caplyta | $129 |
| Abbvie | Meals · 2025-06-07 | Vraylar | $24 |
| Axsome Therapeutics | Honoraria · 2025-06-05 | Auvelity | $5,738 |
| Axsome Therapeutics | Meals · 2025-06-05 | Auvelity | $25 |
| Axsome Therapeutics | Meals · 2025-06-05 | Auvelity | $116 |
| Axsome Therapeutics | Travel · 2025-06-05 | Auvelity | $232 |
| Axsome Therapeutics | Travel · 2025-06-05 | Auvelity | $5 |
| Axsome Therapeutics | Travel · 2025-06-05 | Auvelity | $231 |
| Axsome Therapeutics | Travel · 2025-06-05 | Auvelity | $502 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-06-05 | Caplyta | $1,320 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-03 | Caplyta | $9 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-05-30 | Cobenfy | $733 |
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-05-30 | Cobenfy | $3,220 |
| Axsome Therapeutics | Meals · 2025-05-30 | Auvelity | $47 |
| Axsome Therapeutics | Meals · 2025-05-30 | Auvelity | $12 |
| Axsome Therapeutics | Meals · 2025-05-30 | Auvelity | $44 |
| Axsome Therapeutics | Meals · 2025-05-30 | Auvelity | $6 |
| Axsome Therapeutics | Meals · 2025-05-30 | Auvelity | $22 |
| Axsome Therapeutics | Meals · 2025-05-30 | Auvelity | $5 |
| Axsome Therapeutics | Travel · 2025-05-30 | Auvelity | $57 |
| Axsome Therapeutics | Travel · 2025-05-30 | Auvelity | $66 |
| Axsome Therapeutics | Travel · 2025-05-30 | Auvelity | $94 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-29 | Caplyta | $130 |
| Vanda Pharmaceuticals | Meals · 2025-05-28 | Fanapt | $99 |
| Vanda Pharmaceuticals | Paid to speak or teach · 2025-05-28 | Fanapt | $2,520 |
| Vanda Pharmaceuticals | Travel · 2025-05-28 | Fanapt | $413 |
| Abbvie | Consulting · 2025-05-27 | Vraylar | $900 |
| Axsome Therapeutics | Honoraria · 2025-05-22 | Auvelity | $1,350 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-05-21 | Cobenfy | $182 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-05-21 | Cobenfy | $10 |
| Lundbeck | Meals · 2025-05-21 | Rexulti | $33 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-20 | Cobenfy | $20 |
| Axsome Therapeutics | Meals · 2025-05-20 | Auvelity | $27 |
| Axsome Therapeutics | Honoraria · 2025-05-19 | Auvelity | $1,350 |
| Axsome Therapeutics | Honoraria · 2025-05-15 | Auvelity | $1,350 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-05-14 | Rexulti | $105 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-13 | Cobenfy | $121 |
| Vanda Pharmaceuticals | Meals · 2025-05-13 | Fanapt | $27 |
| Axsome Therapeutics | Meals · 2025-05-13 | Auvelity | $33 |
| Axsome Therapeutics | Honoraria · 2025-05-13 | Auvelity | $1,350 |
| Axsome Therapeutics | Honoraria · 2025-05-12 | Auvelity | $1,350 |
| Otsuka America Pharmaceutical | Paid to speak or teach · 2025-05-09 | Rexulti | $351 |
| Vanda Pharmaceuticals | Paid to speak or teach · 2025-05-09 | Fanapt | $2,100 |
| Vanda Pharmaceuticals | Travel · 2025-05-09 | Fanapt | $335 |
| Vanda Pharmaceuticals | Meals · 2025-05-09 | Fanapt | $39 |
| Abbvie | Meals · 2025-05-06 | Vraylar | $34 |
| Abbvie | Meals · 2025-05-06 | Vraylar | $25 |
| Axsome Therapeutics | Honoraria · 2025-05-06 | Auvelity | $3,038 |
| Axsome Therapeutics | Travel · 2025-05-06 | Auvelity | $322 |
| Neurocrine BioSciences | Consulting · 2025-05-04 | Ingrezza | $6,888 |
| Axsome Therapeutics | Honoraria · 2025-05-01 | Auvelity | $1,350 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-04-29 | Cobenfy | $739 |
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-04-25 | Cobenfy | $3,220 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-25 | Caplyta | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-04-25 | Caplyta | $2,940 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-25 | Caplyta | $552 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-25 | Caplyta | $64 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-25 | Caplyta | $343 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-25 | Caplyta | $123 |
| Axsome Therapeutics | Honoraria · 2025-04-24 | Auvelity | $6,413 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-24 | Caplyta | $119 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-04-24 | Caplyta | $3,360 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-24 | Caplyta | $552 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-24 | Caplyta | $64 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-04-24 | Caplyta | $3,780 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-24 | Caplyta | $552 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-24 | Caplyta | $64 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-04-23 | Caplyta | $5,040 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-23 | Caplyta | $552 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-23 | Caplyta | $64 |
| Axsome Therapeutics | Meals · 2025-04-22 | Auvelity | $13 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-22 | Caplyta | $15 |
| Axsome Therapeutics | Consulting · 2025-04-21 | None | $5,000 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Paid to speak or teach · 2025-04-17 | Caplyta | $2,100 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Travel · 2025-04-17 | Caplyta | $327 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-17 | Caplyta | $149 |
| Axsome Therapeutics | Honoraria · 2025-04-16 | Auvelity | $1,350 |
| Axsome Therapeutics | Meals · 2025-04-15 | Auvelity | $8 |
| Neurocrine BioSciences | Meals · 2025-04-15 | Ingrezza | $15 |
| Axsome Therapeutics | Travel · 2025-04-12 | Auvelity | $733 |
| Axsome Therapeutics | Travel · 2025-04-12 | Auvelity | $305 |
| Axsome Therapeutics | Meals · 2025-04-11 | Auvelity | $73 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-09 | Cobenfy | $102 |
| Abbvie | Meals · 2025-04-08 | Vraylar | $26 |
| Neurocrine BioSciences | Travel · 2025-04-06 | Ingrezza | $469 |
| Neurocrine BioSciences | Travel · 2025-04-06 | Ingrezza | $83 |
| Neurocrine BioSciences | Meals · 2025-04-05 | Ingrezza | $49 |
| Neurocrine BioSciences | Meals · 2025-04-05 | Ingrezza | $28 |
| Neurocrine BioSciences | Meals · 2025-04-05 | Ingrezza | $8 |
| Neurocrine BioSciences | Meals · 2025-04-05 | Ingrezza | $37 |
| Neurocrine BioSciences | Meals · 2025-04-05 | Ingrezza | $10 |
| Neurocrine BioSciences | Travel · 2025-04-05 | Ingrezza | $243 |
| Neurocrine BioSciences | Meals · 2025-04-05 | Ingrezza | $59 |
| Axsome Therapeutics | Honoraria · 2025-04-04 | Auvelity | $15,863 |
| Neurocrine BioSciences | Travel · 2025-04-04 | Ingrezza | $90 |
| Neurocrine BioSciences | Meals · 2025-04-04 | Ingrezza | $4 |
| Neurocrine BioSciences | Travel · 2025-04-04 | Ingrezza | $182 |
| Neurocrine BioSciences | Travel · 2025-04-04 | Ingrezza | $60 |
| Neurocrine BioSciences | Meals · 2025-04-04 | Ingrezza | $175 |
| Axsome Therapeutics | Honoraria · 2025-04-03 | Auvelity | $11,475 |
| Axsome Therapeutics | Honoraria · 2025-04-03 | Auvelity | $1,350 |
| Axsome Therapeutics | Meals · 2025-04-03 | Auvelity | $14 |
| Axsome Therapeutics | Travel · 2025-04-03 | Auvelity | $168 |
| E.R. Squibb & Sons L.L.C. | Travel · 2025-04-02 | Cobenfy | $37 |
| Axsome Therapeutics | Honoraria · 2025-04-02 | Auvelity | $1,350 |
| Axsome Therapeutics | Honoraria · 2025-04-02 | Auvelity | $1,350 |
| Teva Pharmaceuticals USA | Meals · 2025-04-01 | Austedo Xr | $20 |
| E.R. Squibb & Sons L.L.C. | Paid to speak or teach · 2025-03-31 | Cobenfy | $2,300 |
| Axsome Therapeutics | Meals · 2025-03-28 | Auvelity | $3 |
| Axsome Therapeutics | Travel · 2025-03-28 | Auvelity | $215 |
| Axsome Therapeutics | Travel · 2025-03-28 | Auvelity | $5 |
| Axsome Therapeutics | Honoraria · 2025-03-26 | Auvelity | $5,738 |
| Axsome Therapeutics | Meals · 2025-03-26 | Auvelity | $79 |
| Axsome Therapeutics | Travel · 2025-03-26 | Auvelity | $784 |
| Axsome Therapeutics | Travel · 2025-03-26 | Auvelity | $270 |
| Axsome Therapeutics | Education · 2025-03-20 | Auvelity | $52 |
| Axsome Therapeutics | Honoraria · 2025-03-20 | Auvelity | $1,519 |
| Axsome Therapeutics | Honoraria · 2025-03-19 | Auvelity | $5,738 |
| Axsome Therapeutics | Meals · 2025-03-19 | Auvelity | $66 |
| Axsome Therapeutics | Meals · 2025-03-19 | Auvelity | $77 |
| Axsome Therapeutics | Meals · 2025-03-19 | Auvelity | $125 |
| Axsome Therapeutics | Travel · 2025-03-19 | Auvelity | $492 |
| Axsome Therapeutics | Travel · 2025-03-19 | Auvelity | $10 |
| Axsome Therapeutics | Travel · 2025-03-19 | Auvelity | $299 |
| Axsome Therapeutics | Travel · 2025-03-19 | Auvelity | $635 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-18 | Cobenfy | $129 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-18 | Caplyta | $10 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $66 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $48 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $78 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $29 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $33 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $125 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $27 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $45 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $60 |
| Axsome Therapeutics | Meals · 2025-03-15 | Auvelity | $49 |
| Axsome Therapeutics | Travel · 2025-03-15 | Auvelity | $258 |
| Axsome Therapeutics | Travel · 2025-03-15 | Auvelity | $917 |
| Abbvie | Meals · 2025-03-11 | Vraylar | $9 |
| Axsome Therapeutics | Meals · 2025-03-11 | Auvelity | $31 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-11 | Caplyta | $33 |
| Abbvie | Meals · 2025-03-07 | Vraylar | $12 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-03-06 | Ingrezza | $3,088 |
| Neurocrine BioSciences | Travel · 2025-03-06 | Ingrezza | $243 |
| Neurocrine BioSciences | Meals · 2025-03-06 | Ingrezza | $47 |
| Axsome Therapeutics | Meals · 2025-03-05 | Auvelity | $27 |
| Axsome Therapeutics | Honoraria · 2025-03-05 | Auvelity | $3,375 |
| Axsome Therapeutics | Honoraria · 2025-03-05 | Auvelity | $3,038 |
| Axsome Therapeutics | Meals · 2025-03-05 | Auvelity | $5 |
| Axsome Therapeutics | Meals · 2025-03-05 | Auvelity | $88 |
| Axsome Therapeutics | Meals · 2025-03-05 | Auvelity | $97 |
| Axsome Therapeutics | Travel · 2025-03-05 | Auvelity | $863 |
| Axsome Therapeutics | Travel · 2025-03-05 | Auvelity | $208 |
| Axsome Therapeutics | Travel · 2025-03-05 | Auvelity | $918 |
| Abbvie | Meals · 2025-03-04 | Vraylar | $11 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-04 | Trintellix | $23 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $20 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $34 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $49 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $74 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $94 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $110 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $25 |
| Axsome Therapeutics | Meals · 2025-03-01 | Auvelity | $25 |
| Axsome Therapeutics | Travel · 2025-03-01 | Auvelity | $304 |
| Axsome Therapeutics | Travel · 2025-03-01 | Auvelity | $400 |
| Axsome Therapeutics | Meals · 2025-02-28 | Auvelity | $32 |
| Axsome Therapeutics | Honoraria · 2025-02-26 | Auvelity | $2,500 |
| Axsome Therapeutics | Meals · 2025-02-26 | Auvelity | $50 |
| Axsome Therapeutics | Travel · 2025-02-26 | Auvelity | $376 |
| Axsome Therapeutics | Travel · 2025-02-26 | Auvelity | $1,155 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-02-26 | Ingrezza | $3,800 |
| Neurocrine BioSciences | Travel · 2025-02-26 | Ingrezza | $819 |
| Neurocrine BioSciences | Travel · 2025-02-26 | Ingrezza | $232 |
| Neurocrine BioSciences | Meals · 2025-02-26 | Ingrezza | $122 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-02-25 | Ingrezza | $3,800 |
| Neurocrine BioSciences | Travel · 2025-02-25 | Ingrezza | $946 |
| Neurocrine BioSciences | Travel · 2025-02-25 | Ingrezza | $223 |
| Neurocrine BioSciences | Meals · 2025-02-25 | Ingrezza | $71 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-02-19 | Ingrezza | $2,975 |
| Neurocrine BioSciences | Travel · 2025-02-19 | Ingrezza | $478 |
| Neurocrine BioSciences | Meals · 2025-02-19 | Ingrezza | $110 |
| Axsome Therapeutics | Meals · 2025-02-18 | Auvelity | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-18 | Caplyta | $21 |
| Vanda Pharmaceuticals | Paid to speak or teach · 2025-02-12 | Fanapt | $1,920 |
| Vanda Pharmaceuticals | Travel · 2025-02-12 | Fanapt | $321 |
| Vanda Pharmaceuticals | Meals · 2025-02-12 | Fanapt | $45 |
| Neurocrine BioSciences | Meals · 2025-02-12 | Ingrezza | $37 |
| Lundbeck | Meals · 2025-02-12 | Rexulti | $24 |
| Neurocrine BioSciences | Meals · 2025-02-04 | Ingrezza | $40 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-03 | Cobenfy | $116 |
| Axsome Therapeutics | Honoraria · 2025-01-30 | Auvelity | $500 |
| Axsome Therapeutics | Meals · 2025-01-29 | Auvelity | $24 |
| Vanda Pharmaceuticals | Meals · 2025-01-23 | Fanapt | $115 |
| Vanda Pharmaceuticals | Paid to speak or teach · 2025-01-23 | Fanapt | $2,520 |
| Vanda Pharmaceuticals | Travel · 2025-01-23 | Fanapt | $387 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-17 | Caplyta | $31 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-01-16 | Ingrezza | $2,975 |
| Neurocrine BioSciences | Meals · 2025-01-16 | Ingrezza | $121 |
| Neurocrine BioSciences | Travel · 2025-01-16 | Ingrezza | $63 |
| Neurocrine BioSciences | Meals · 2025-01-15 | Ingrezza | $45 |
| Abbvie | Meals · 2025-01-14 | Vraylar | $6 |
| Axsome Therapeutics | Meals · 2025-01-14 | Auvelity | $28 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-01-08 | Ingrezza | $3,400 |
| Neurocrine BioSciences | Paid to speak or teach · 2025-01-08 | Ingrezza | $2,975 |
| Neurocrine BioSciences | Travel · 2025-01-08 | Ingrezza | $415 |
| Neurocrine BioSciences | Travel · 2025-01-08 | Ingrezza | $176 |
| Neurocrine BioSciences | Meals · 2025-01-08 | Ingrezza | $37 |
| Lundbeck | Meals · 2025-01-08 | Rexulti | $27 |
| Axsome Therapeutics | Meals · 2025-01-07 | Auvelity | $10 |
| Neurocrine BioSciences | Meals · 2025-01-07 | Ingrezza | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $266,361
| Axsome Therapeutics | Auvelity | $127,998 | 178 payments
|
| Neurocrine Biosciences | Ingrezza | $50,891 | 67 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $31,936 | 46 payments
|
| Abbvie | Vraylar | $20,581 | 40 payments
|
| Otsuka America Pharmaceutical | Rexulti | $11,438 | 17 payments
|
| Vanda Pharmaceuticals | Fanapt | $11,036 | 14 payments
|
| Teva Pharmaceuticals USA | Uzedy | $8,836 | 24 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $3,322 | 16 payments
|
| Lundbeck | Rexulti | $212 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $55 | 2 payments
|
| Eisai | Leqembi | $55 | 2 payments
|
2023: $288,855
| Axsome Therapeutics | Auvelity | $115,045 | 188 payments
|
| AbbVie | Vraylar | $99,179 | 145 payments
|
| Iti | Caplyta | $42,403 | 60 payments
|
| Teva Pharmaceuticals USA | Uzedy | $16,559 | 44 payments
|
| Otsuka America Pharmaceutical | Rexulti | $15,217 | 19 payments
|
| Neurocrine Biosciences | Ingrezza | $224 | 6 payments
|
| Corium | Adlarity | $77 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $64 | 2 payments
|
| Lundbeck | Rexulti | $60 | 3 payments
|
| Indivior | Perseris | $27 | 1 payment
|
2022: $118,979
| Iti | Caplyta | $68,149 | 86 payments
|
| Abbvie | Vraylar | $26,141 | 64 payments
|
| Otsuka America Pharmaceutical | Rexulti | $13,254 | 17 payments
|
| Teva Pharmaceuticals USA | Austedo | $11,078 | 12 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $121 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $89 | 3 payments
|
| Axsome Therapeutics | Auvelity | $74 | 2 payments
|
| Alkermes | Aristada | $47 | 2 payments
|
| Lundbeck | Rexulti | $25 | 1 payment
|
2021: $55,622
| Iti | Caplyta | $19,610 | 30 payments
|
| AbbVie | Vraylar | $13,546 | 39 payments
|
| Sunovion Pharmaceuticals | Latuda | $8,551 | 16 payments
|
| Otsuka America Pharmaceutical | Rexulti | $7,067 | 23 payments
|
| Teva Pharmaceuticals USA | Austedo | $6,660 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $130 | 4 payments
|
| Lundbeck | Rexulti | $33 | 1 payment
|
| Alkermes | Lybalvi | $25 | 1 payment
|
2020: $87,201
| Allergan | Vraylar | $51,002 | 154 payments
|
| Sunovion Pharmaceuticals | Latuda | $26,002 | 54 payments
|
| Iti | Caplyta | $4,675 | 11 payments
|
| Otsuka America Pharmaceutical | Rexulti | $2,992 | 9 payments
|
| Teva Pharmaceuticals USA | Austedo | $2,411 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $119 | 5 payments
|
2019: $161,014
| Allergan | Vraylar | $75,411 | 294 payments
|
| Sunovion Pharmaceuticals | Latuda | $55,097 | 119 payments
|
| Otsuka America Pharmaceutical | Rexulti | $20,471 | 67 payments
|
| Teva Pharmaceuticals USA | Austedo | $8,599 | 19 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $828 | 14 payments
|
| Lundbeck | Rexulti | $295 | 15 payments
|
| Allergan | Viibryd | $200 | 1 payment
|
| Shire North American Group | Vyvanse | $45 | 3 payments
|
| Otsuka Pharmaceutical Development & Commercialization | Rexulti | $36 | 1 payment
|
| Vanda Pharmaceuticals | Fanapt | $33 | 1 payment
|
Professional record
- NPI
- 1528012374
- Licence
- CA A8212California A8212: Deceased
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 2680 Hanover St, Palo Alto, CA, 94304
- NPI first listed
- 2006-05-19
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.